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SurgeryAbstract Introduction: Paragangliomas are extra-adrenal tumors originating from the neuro-
ectoderm, occurring from the skull base to the pelvic ﬂoor. In the head and neck region, they
are found at the jugular bulb, the vagal and tympanic nerves and the aortic glomus.
Objectives: The aim of the present study was to review clinical proﬁle, treatment outcomes and
long-term follow-up in patients with paragangliomas of the carotid body.
Materials and methods: It is about a retrospective study of 26 patients (28 paragangliomas) fol-
lowed and treated in Ear, Nose and Throat Department of La Rabta Hospital. Pre-, intra- and
postoperative ﬁndings were analyzed.
Results: The present study included 6 men and 20 women. Bilateral involvement of the carotid
glomus was noted in 2 cases and tympano-jugular location was associated in 2 other cases. Ultra-
sound of the neck, computed tomography (CT) and magnetic resonance (MR) tomography were
performed in 13, 17 and 10 cases, respectively. 2 patients have had preoperative embolization
and 22 patients, in total, were operated. External radiation was an exclusive therapeutic option
in 2 patients and adjuvant to incomplete surgery in one patient. Only one case of malignant
paraganglioma was noted that evolution was, in fact, rapidly fatal.
ª 2015 Egyptian Society of Ear, Nose, Throat and Allied Sciences. Production and hosting by Elsevier
B.V. All rights reserved.Contents
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Carotid paragangliomas are tumors developed from chromaf-
ﬁn cells of the extra-adrenal tissue. Clinical presentation of
these tumors may be misleading and the treatment, often,
arduous. Hence, speciﬁc pretreatment assessment is the only
guarantee of adequate management. The development of diag-
nostic and interventional radiology techniques has, obviously,
improved the prognosis of these tumors.
2. Material and methods
Over a 27-year period (1981–2007), 26 patients were treated for
28 carotid paragangliomas in the Ear, Nose and Throat
Department of La Rabta Hospital. Their clinical and operative
data were collected and analyzed retrospectively. Preoperative
work-up in patients with carotid paraganglioma consisted of
careful family history, clinical examination, ultrasound of the
neck, computed tomography (CT) or magnetic resonance
(MR) tomography. The Shamblin classiﬁcation was used to
grade the tumor size. Treatment modality, including the neces-
sity of preoperative interventional embolization, was assessed
by the operating surgeons and vascular radiologist. Postoper-
ative follow-up consisted of clinical evaluation 1 month after
surgery, ultrasound 1 year after and CT or magnetic resonance
imaging (MRI) if new pathological ﬁndings occurred in
ultrasound.
3. Results
Our study includes 26 patients. Mean age was 38 years, rang-
ing from 18 to 75 years. There was a female predominance
with 20 women and 6 men (sex ratio = 0.3). Carotid paragan-
gliomas were bilateral in 2 cases (10%) and associated with
tympano-jugular location in 2 cases.
A family history of paraganglioma was found in 3 cases
who were a patient and his 2 nieces.
– This patient and one of his nieces had a double localization.
Bilateral carotid localization in one case and a carotid par-
aganglioma associated with contralateral jugular location in
the other case.
– The last patient had a carotid body paraganglioma on a sin-
gle side.
Consultation average delay was 3 years (6 months–
15 years). The chief complaint was a slowly growing, painless
lateral neck mass associated with high dysphagia in one case.
The carotid paraganglioma was an incidental ﬁnding on the
occasion of an MRI angiography performed as part of explo-
rations of tympano-jugular paraganglioma in 1 case.
The paraganglioma was discovered intraoperatively during
a cervicotomy performed for a supposed chronic lymphade-
nopathy in 3 cases.Symptoms related to catecholamines release, giving place to
hypertensive crises and arrhythmias, were not reported in our
patients.
On physical examination, themass was located at the high or
middle jugulo-carotid region. Its average size was 4 cm (range
from 2 to 6 cm). Limited mobility in transverse direction has
been reported in 14 cases (54%). Pulse-like sensation and pal-
pated thrill, testifying the vascular character, were noted in 14
(54%) and 2 cases (9%) respectively. Examination of the oro-
pharynx allowed objectifying a parapharyngeal bulge in 1 case.
Otoscopic examination revealed the existence of a bleeding
tumor ﬁlling the external auditory canal in 2 cases.
Ultrasound of the neck was performed in 13 patients. It was
suggestive of the diagnosis in 7 cases showing a well limited
hypoechoic solid mass, located in the carotid bifurcation and
vascularized in Doppler ultrasound exam. In the other cases,
it evoked a cervical lymphadenopathy except in one case where
it was in favor of a parotid tumor.
CT was performed in 17 patients. It helped to advance the
diagnosis in 15 cases. The suggestive aspect was that of a car-
otid space mass which splays the internal and external carotid
arteries at the level of the bifurcation and demonstrates intense
homogenous enhancement following the intravenous adminis-
tration of iodinated contrast (Fig. 1).
In one case, the evoked diagnosis was metastatic lymphad-
enopathy due to the presence of a thyroid suspicious nodule in
both ultrasound and cytology.
The MRI was performed in 10 patients. The carotid para-
ganglioma took the appearance of a lesion sitting at the carotid
bifurcation with intermediate and heterogeneous signal on T1
and T2 sequences. Hypointense ﬂow voids of punctuate, ser-
piginous or channel-like structures on the set of sequences,
achieving an aspect of ‘‘salt and pepper’’ is a distinctive feature
in MRI. Intense and homogenous enhancement following the
intravenous administration of gadolinium is the last character
noted in our patients (Fig. 2).
The MR angiography, performed in 2 patients, showed the
spacing of the carotid bifurcation and conﬁrmed the perme-
ability of vessels. It also showed the absence of the posterior
communicating artery in 1 case. Nevertheless MR angiography
was not able to identify the feeding pedicles in our study.
Angiography was performed in 16 patients allowing to con-
ﬁrm the diagnosis in all cases (Fig. 3).
Biologically, measurement of urinary VMA (vanillylman-
delic acid) was performed in 12 patients. It was normal in all
cases.
A ﬁne needle aspiration was performed in 10 patients with-
out incident, fortunately. It was inconclusive in 9 cases and in
favor of metastatic lymphadenopathy in 1 case.
Concerning treatment, 22 patients were operated. Two
patients had both large tympano-jugular and carotid paragan-
gliomas. One of them received radiation therapy to the ﬁrst loca-
tion and was operated for the second one. The other was lost.
Three patients have already had a cervicotomy in
another department for the diagnosis of chronic cervical
Figure 1 CT sagittal (a) axial (b) sections and 3D view: carotid space mass which splays the internal and external carotid arteries at the
level of the bifurcation and demonstrates intense homogenous enhancement following the intravenous administration of iodinated
contrast.
Figure 2 MRI axial sections in T1 (a), T2 (b) sequences and after administration of gadolinium (c): lesion sitting at the carotid
bifurcation with intermediate and heterogeneous signal on T1 and T2 sequences achieving an aspect of ‘‘salt and pepper’’ with intense and
homogenous enhancement following the intravenous administration of gadolinium.
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Figure 3 Angiography aspect of a paraganglioma showing the
spacing of the carotid bifurcation and conﬁrming the permeability
of vessels.
22 Z. Rim et al.lymphadenopathy. Reoperation was performed within 3–15 days.
Tumor size was of 3, 4 and 6 cm. The dissection was compli-
cated by a vascular wound of the external carotid artery which
was sutured in the latter two cases.
The latero-cervical approach was performed in all cases.
Resection was complete in 21 cases. In one case, residual
tumor was left due to vascular wound.
2 cases of bilateral carotid paragangliomas were operated
separately with an interval between 6 and 12 months. The ﬁrst
intervention, in fact, was conducted without complications.
Reported intraoperative incidents were:
– Internal carotid artery wound that was sutured by perform-
ing an end-to-end anastomosis.
– Common carotid artery wound 2 cm below bifurcation that
was, also, sutured.
Otherwise, the external carotid was sacriﬁced in 7 cases in
front of tumor invading this vessel. The internal jugular vein
has been sacriﬁced in two cases and the descending branch
of the hypoglossal nerve (XII) was sacriﬁced in 3 cases.
Early postoperative period was marked by cervical hema-
toma in one patient, known hypertensive, with hemorrhagic
shock requiring rapid surgical revision.Figure 4 MRI T1 sequences: right temporal metastasis extended
to the nasopharynx and parapharyngeal spaces and right frontal
metastasis invading the eyeball and superﬁcial planes.Radiotherapy was the ﬁrst therapeutic choice in 2 cases.
Reasons were a carotid paraganglioma with intracranial exten-
sion invading the cavernous sinus in 1 case and a large para-
ganglioma adjoining the internal carotid with extension to
parapharyngeal spaces and compressing the aero-digestive
tract in the other case (type III of Shamblin in both cases).
Radiation therapy completed incomplete surgical resection
in 1 case.
No recurrence was noted. 8 years after surgery, one patient
developed a right temporal lesion extended to the nasopharynx
and parapharyngeal spaces and a right frontal lesion invading
the eyeball and superﬁcial planes (Fig. 4). Biopsy concluded
the paraganglionar tissue. The evolution was rapidly fatal
despite external ﬂush radiation therapy. 2 patients were lost
to follow up. The mean follow-up was 5 years.4. Discussion
Paragangliomas are rare neoplasms. Their incidence is esti-
mated at less than 0.03%. Their frequency is underestimated
since they are sometimes asymptomatic.1
They arise from the neural crest located in extra-adrenal
locations. In most cases, they are found in the head and neck
region, especially as highly vascularized carotid body (CBT) or
glomus tumors.2 They are related to the parasympathetic ner-
vous system and are found near the arteries and cranial nerves.
Their etiology is still unknown.1,2 It was noted a high inci-
dence of carotid paraganglioma in patients suffering from
chronic pulmonary disease and those living at high altitude.3
In fact, chronic hypoxia can induce hypertrophy of carotid
glomus cells which detect blood pressure changes in oxygen,
carbon dioxide and pH.3 The resulting lesions are referred to
as non-heritable or sporadic tumors. In the sporadic form, a
female predominance was reported.1–3
Regarding family form, it represents 10% of cases.4,5 Its
mode of inheritance is autosomal dominant with variable pen-
etrance and is characterized by the frequency of bilateral
forms.4,5 It is caused by germline mutations of genes associated
with the mitochondrial succinate dehydrogenase complex
(SDHD, SDHB, SDHC or SDHAF2).
Clinically, patients notice a slowly growing, painless lateral
neck mass located just anterior to the sterno-cleido-mastoid
muscle at the level of the hyoid bone. Due to the proximity
to the visceral axis of the neck, and the 10th and 12th cranial
nerve, symptoms like cranial nerve palsies, voice changes or
auditory defects are possible but not common.1,2,6
Patients with carotid paraganglioma can report clinical
signs of catecholamines hypersecretion like high blood pres-
sure, palpitations, and diarrhea.6–8
The tumor is typically moveable in the horizontal plane,
but mobility is limited vertically (fountain sign). Carotid para-
gangliomas can be beating, transmitting the carotid pulse and
producing a thrill.6,7
Differential diagnoses include: cervical lymphadenopathy,
carotid aneurysms, laryngeal tumors and metastatic tumors.6
In the majority of cases the tumors are benign, but in up to
5% malignant.1,2,9 Malignancy in paraganglioma is deﬁned by
the conﬁrmation of metastases in non-neuro-ectoderm tissue
such as lymphnodes.9,10 Tumor size is not amalignant factor.9,10
These metastases can affect the kidneys, lungs, brain and pan-
creas.9–11 They are, often, limited to the cervical region.9–11
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nosis.12,13 Conventional angiography may show the classic
tumor ‘‘blush’’ and is important if embolization is to be
attempted to minimize intra-operative bleeding.12,13
Radionuclide imaging uses an octreotide marked with
Indium, labeled DTPA (pentetreotide). It binds somatostatin
type 2 receptors common to paragangliomas. It is advocated
if multicentricity is suspected in familial disease or to seek
postoperative residual tumor.
The management of cervical paraganglioma has been
controversial given morbidity rates (32–44%) and mortality
(5–13%) following surgery of this benign tumor.14–16
Currently postoperative mortality is estimated between 1%
and 2%, but the morbidity related to cranial nerve lesions
remains high (40%).14–16 However, surgery remains the only
curative treatment.14–16
Radiation therapy is indicated only in some patients or fol-
lowing surgery.17–19 It seems to be a useful alternative in case
of unresectable lesions, in patients with anesthetic high risk
and in addition to surgery in cases of incomplete resection
and ﬁnally in malignant paraganglioma.17–20
Clinical, biochemical and radiological ﬁndings cannot nei-
ther distinguish benign from malignant lesions nor predict
malignancy evolution. In fact, malignancy is established in
the presence of distant metastases mainly to the liver, lymph
nodes, lung and/or bone either at diagnosis or during follow-
up. Local invasion and various histopathological features
can be suggestive. However, these features are not widely
accepted. At present there is no universally effective therapy
for malignant chromafﬁn-cell tumors. Most treatments are
palliative, although there is a great variability in patients’
responses.21
5. Conclusion
Carotid paragangliomas are rare neoplasms. They still pose
several diagnostic and mainly therapeutic challenges. The lack
of ﬁrm predictors of malignancy, coupled with the variable
course of this rare disease, make life-long follow-up of patients
with chromafﬁn-cell tumors, paragangliomas included,
mandatory.
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